In this interview, biologist and aging expert Dr. Steven Austad joins host Don MacPherson to discuss how and why we age, various ways to extend human life, and ethical questions that accompany a 100-year life expectancy. They also dive into medical treatments that show signs of slowing the aging process, the impossibility of immortality, and the societal changes that will occur if we all live longer.
Dr. Austad has dedicated his career to understanding the science of how and why we age. He is a distinguished professor and Chair of the Biology Department at the University of Alabama at Birmingham. He has also authored numerous books, academic papers, and articles on aging.
A generation ago, a cancer diagnosis meant the patient had a 50% chance of living beyond five years. Today, cancer is still an awful disease, but thanks to incredible medical advances, survival is far more likely than ever before. That’s not the only good news. In fact, there is hope that as soon as a decade from now, cancer could possibly be a managed disease instead of a killer.
In this episode, pharmaceutical expert and cancer researcher, Sara Kenkare-Mitra, shares her how she got into the pharmaceutical field, the long road to creating an effective drug, and the importance of celebrating failure.
Sara discusses:
Part One: The Road to Making a Drug
Growing up in India, moving from India to the United States, culture shock, building resilience, joining Genentech, becoming a leader, how her leadership skills as a manager needed to evolve to lead a team of 550 people, the importance of technical competence in a large organization, the drug development process.
Part Two: Curing Cancer
Why it’s good to celebrate failure, how pharmaceutical companies are curing cancer, advice for young women entering STEM fields, encouraging your teams to learn from failures, meditation and leadership, overcoming the minority effect, advocating for yourself, how being a mother made her a more effective leader, the future of cancer, the role of empathy in leadership and drug development.
Organizations, People, Resources, Places Mentioned.
Mumbai, India, Genentech, Austin, Texas, University of Texas - Austin, UCSF (University of California, San Francisco), San Francisco, Kadcyla (Her2+ Breast cancer drug), the FDA (U.S. Food & Drug Administration)
To learn more about Sara and Genentech, please visit www.Gene.com.
Read More
Thirty years ago, just 16% of Americans favored the legalization of marijuana. Now, 90% support legalization for medical purposes. For people who experience chronic pain, medical cannabis can be a highly effective, affordable treatment. Ten states have legalized recreational use in the United States and 33 have legalized it for medical use. This had sparked incredible opportunity both in the job market and as an investment.
As cannabis rapidly expands in the global market, we all stand to gain advancements in medical treatment, cheaper energy storage, energy efficient crops, and an explosive new job market. In this episode, serial entrepreneur and cannabis expert Giadha Aguirre de Carcer shares her knowledge of cannabis uses, the global market, and the future of cannabis.
Giadha discusses:
Part One: Changing the Dialogue on Cannabis
Being a serial entrepreneur, starting New Frontier Data, working in the field of United States intelligence, being a female tech entrepreneur, the differences in cannabis terms (CBD vs THC vs Hemp), The Farm Bill, the shift in public opinion on cannabis, medical purposes of cannabis, cannabis user profiles (discrete, weekend, medical, etc.), top ten reasons for cannabis consumption, alternative medical applications for cannabis, federal legalization of cannabis.
Part Two: The Market & Future of Cannabis
Global hemp market, cannabis as an alternative to opioids, Big Agriculture’s position in the hemp market, cannabis consumption rates, cannabis investments, creating company policies where cannabis is legal, police testing for cannabis impaired driving, the best locations for cannabis production.
Organizations, People, Resources, Places Mentioned:
New Frontier Data, University of Pennsylvania, Georgetown University, Progressive, Verizon, China, The Farm Bill, Colorado, California, Martha Stewart, A.G. William Barr, Obama and Trump administrations, Australia, Florida, Mercedes-Benz and BMW
Contact info for New Frontier Data:
“I did finally convince her to take some CBD pills. It changed her life. She woke up one morning crying saying to me she had forgotten what it was like to not feel pain.”
Giadha Aguirre de Carcer talking about her mother using CBD instead of the opioids she was originally recommended
Read More